INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• From Complexity To Clarity: Automate eCOA Configuration With AI

  Clinical trials are more complex than ever, but building and launching global studies doesn’t have to be.

• Artificial Intelligence, Virtual Participants, and the Evolving FDA Regulatory Landscape

  Understanding emerging requirements around transparency, risk, and governance is essential for responsibly advancing AI-driven innovation in regulated environments.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Transforming Clinical Trial Disclosure With AI

  Unlock the full potential of AI to address sponsor challenges including regulatory complexity, clinical trial disclosure requirements, and growing demands for transparency.

• Customer Testimonial – Keya Watkins, SVP, Oncology, Catalyst

  6/26/2024

  Join Keya Watkins, SVP of Oncology at Catalyst, as she discusses the transformative impact of Rave EDC in enhancing competitiveness and sponsor engagement in oncology trials.

• 10 Questions To Ask When Looking For An eClinical Platform

  7/2/2024

  Stakeholders should ask these questions when aiming to enhance the integrity and efficiency of their clinical trials while minimizing risks associated with inadequate eClinical solutions.

• Defining And Implementing The Right Oncology Digital Strategy

  11/7/2024

  A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.

• How Sponsors Can Ensure Their Sites Are Aligned With ICH E6 R3

  4/14/2026

  Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

• Cytokine Release Syndrome Monitoring

  2/7/2025

  Here we introduce an innovative risk-monitoring solution aimed at mitigating Cytokine Release Syndrome (CRS), a critical complication in immunotherapy that often leads to prolonged hospitalization.